α-MSH: A potential neuroprotective and immunomodulatory agent for the treatment of stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 2, 2011, Pages 606-613

  Savos, Anna V ^a   Gee, J Michael ^a   Zierath, Dannielle ^a   Becker, Kyra J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

animal models; immunology; inflammation; neuroprotection; T cells

Indexed keywords

ALPHA INTERMEDIN; MYELIN BASIC PROTEIN; PHYTOHEMAGGLUTININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; IMMUNOMODULATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; STROKE; TH1 CELL;

ALPHA-MSH; ANIMALS; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGIC FACTORS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MYELIN PROTEOLIPID PROTEIN; NEUROPROTECTIVE AGENTS; PHYTOHEMAGGLUTININS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; SPLEEN; STROKE; TREATMENT OUTCOME;

EID: 79551653962     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.130     Document Type: Article

References (39)

1. Bai XF, Li HL, Shi FD, Liu JQ, Xiao BG, Van der Meide PH, Link H (1998) Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats. Clin Exp Immunol 111:205-10
2. Becker K, Kindrick D, McCarron R, Hallenbeck J, Winn R (2003) Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury? Stroke 34:1809-15
3. Becker KJ, Kindrick DL, Lester MP, Shea C, Ye ZC (2005) Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J Cereb Blood Flow Metab 25:1634-44
4. Becker KJ, McCarron RM, Ruetzler C, Laban O, Sternberg E, Flanders KC, Hallenbeck JM (1997) Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci USA 94:10873-8
5. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-6
6. Blanas E, Carbone FR, Allison J, Miller JF, Heath WR (1996) Induction of autoimmune diabetes by oral administration of autoantigen. Science 274:1707-9
7. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL (2002) Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5:514-6
8. Brzoska T, Luger TA, Maaser C, Abels C, Bohm M (2008) Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 29:581-602
9. Catania A, Cutuli M, Garofalo L, Airaghi L, Valenza F, Lipton JM, Gattinoni L (2000) Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Crit Care Med 28:1403-7
10. Chen G, Frokiaer J, Pedersen M, Nielsen S, Si Z, Pang Q, Stodkilde-Jorgensen H (2008) Reduction of ischemic stroke in rat brain by alpha melanocyte stimulating hormone. Neuropeptides 42:331-8
11. Chen Y, Ruetzler C, Pandipati S, Spatz M, McCarron RM, Becker K, Hallenbeck JM (2003) Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury. Proc Natl Acad Sci USA 100: 15107-12
12. Ding Y, Zhou Y, Lai Q, Li J, Park H, Diaz FG (2002) Impaired motor activity and motor learning function in rat with middle cerebral artery occlusion. Behav Brain Res 132:29-36
13. Forslin Aronsson S, Spulber S, Popescu LM, Winblad B, Post C, Oprica M, Schultzberg M (2006) Alpha-melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides 40:65-75
14. Frenkel D, Huang Z, Maron R, Koldzic D, Hancock W, Moskowitz M, Weiner H (2003) Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J Immunol 171:6549-55
15. Frenkel D, Huang Z, Maron R, Koldzic DN, Moskowitz MA, Weiner HL (2005) Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci 233:125-32
16. Gee JM, Kalil A, Thullbery M, Becker KJ (2008) Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. Stroke 39:1575-82
17. Gee JM, Zierath D, Hadwin J, Savos A, Kalil A, Thullbery M, Becker KJ (2009) Long term immunologic consequences of experimental stroke and mucosal tolerance. Exp Transl Stroke Med 1:3
18. Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C, Raine CS, Hauser SL (1996) Late complications of immune deviation therapy in a nonhuman primate. Science 274:2054-7
19. Giuliani D, Leone S, Mioni C, Bazzani C, Zaffe D, Botticelli AR, Altavilla D, Galantucci M, Minutoli L, Bitto A, Squadrito F, Guarini S (2006a) Broad therapeutic treatment window of [Nle(4), D-Phe(7)]alpha-melano-cyte- stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils. Eur J Pharmacol 538:48-56
20. Giuliani D, Mioni C, Altavilla D, Leone S, Bazzani C, Minutoli L, Bitto A, Cainazzo MM, Marini H, Zaffe D, Botticelli AR, Pizzala R, Savio M, Necchi D, Schioth HB, Bertolini A, Squadrito F, Guarini S (2006b) Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 147:1126-35
21. Giuliani D, Ottani A, Mioni C, Bazzani C, Galantucci M, Minutoli L, Bitto A, Zaffe D, Botticelli AR, Squadrito F, Guarini S (2007) Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocor-tins. Eur J Pharmacol 570:57-65
22. Han D, Tian Y, Zhang M, Zhou Z, Lu J (2007) Prevention and treatment of experimental autoimmune encephalo-myelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific Tcells. Gene Ther 14:383-95
23. Hernandez TD, Schallert T (1988) Seizures and recovery from experimental brain damage. Exp Neurol 102:318-24
24. Huh SK, Lipton JM, Batjer HH (1997) The protective effects of alpha-melanocyte stimulating hormone on canine brain stem ischemia. Neurosurgery 40:132-9; discussion 9-40
25. Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E, Hadingham SJ, Parsons AA (2000) Functional assessments in mice and rats after focal stroke. Neuropharmacology 39:806-16
26. Magnoni S, Stocchetti N, Colombo G, Carlin A, Colombo A, Lipton JM, Catania A (2003) Alpha-melanocyte-stimu-lating hormone is decreased in plasma of patients with acute brain injury. J Neurotrauma 20:251-60
27. Namba K, Kitaichi N, Nishida T, Taylor AW (2002) Induction of regulatory T cells by the immunomodulat-ing cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J Leukoc Biol 72:946-52
28. Ng TF, Kitaichi N, Taylor AW (2007) In vitro generated autoimmune regulatory T cells enhance intravitreous allogeneic retinal graft survival. Invest Ophthalmol Vis Sci 48:5112-7
29. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198:725-36
30. Redding TW, Kastin AJ, Nikolics K, Schally AV, Coy DH (1978) Disapearance and excretion of labeled alpha-MSH in man. Pharmacol Biochem Behav 9:207-12
31. Reith ME, Neidle A (1981) Breakdown and fate of ACTH and MSH. Pharmacol Ther 12:449-61
32. Saland LC (2001) The mammalian pituitary intermediate lobe: an update on innervation and regulation. Brain Res Bull 54:587-93
33. Schulte-Herbruggen O, Quarcoo D, Brzoska T, Klehmet J, Meisel A, Meisel C (2008) Alpha-MSH promotes spontaneous post-ischemic pneumonia in mice via melanocortin-receptor-1. Exp Neurol 210:731-9
34. Taylor A, Namba K (2001) In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol Cell Biol 79:358-67
35. Taylor AW, Kitaichi N (2008) The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy. Brain Behav Immun 22:639-46
36. Taylor AW, Streilein JW, Cousins SW (1994) Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation 1:188-94
37. Todd SR, Kao LS, Catania A, Mercer DW, Adams SD, Moore FA (2009) Alpha-melanocyte stimulating hormone in critically injured trauma patients. J Trauma 66:465-9
38. Xiao BG, Link H (1997) Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases. Clin Immunol Immunopathol 85:119-28
39. Zierath D, Thullbery M, Hadwin J, Gee JM, Savos A, Kalil A, Becker KJ (2010) CNS immune responses following experimental stroke. Neurocrit Care 12:274-84